Sanofi US

200 articles about Sanofi US

• Sanofi-Aventis Announces Commercial Availability Of Twice-Yearly ELIGARD(R)

  2/17/2005

• Appointments At The Communications Department Of Sanofi-Aventis

  2/11/2005

• Eight Pharmaceutical Leaders Initiate New Company To Manage And Promote Digital Identity Assurance Standard Across The Biopharmaceutical Industry

  2/10/2005

• Bated Breath For Inhaled Insulin

  1/31/2005

• International Genomics Consortium Release: Expression Project For Oncology Completes First Phase Of Standardized Gene Expression Analyses

  1/24/2005

• Drug Companies Launch New Discount Card

  1/12/2005

• Sanofi-Aventis SA To Expand, Restructure Generics Operations From January 1

  12/30/2004

• Sanofi-Aventis Shareholders OK Merger

  12/23/2004

• Sanofi-Aventis To Reorganize Short-Term Financing

  12/22/2004

• Sanofi-Aventis Group Release: Taxotere(R) (Docetaxel) Regimen Significantly Improves Survival In Women With Node Positive Early Stage Breast Cancer

  12/10/2004

• Update Of Patent Litigation Schedules In The United States For Plavix(R) And Lovenox(R)

  12/9/2004

• Sanofi-Aventis Group Release: First International Registry Of Patients With Early Stage Breast Cancer Launched

  12/7/2004

• Torre Lazur McCann Creates Consumer Group

  12/3/2004

• Firms Seek To Sell Antibiotic Over Counter In UK

  11/5/2004

• The Alliance For Better Bone Health Release: Actonel Provides Vertebral Fracture Risk Reduction In Women With Postmenopausal Osteoporosis At Risk For Upper GI Side Effects

  10/18/2004

• Sanofi-Aventis Announces Bridgewater, NJ As U.S. Headquarters

  10/13/2004

• New Drugs Slow Metastatic Prostate Cancer

  10/7/2004

• Study Backs Therapy Over Sleeping Pills

  9/29/2004

• Sanofi Takes Top Aventis Board Slots, H1 Net Jumps

  9/1/2004

• Top Sanofi-Aventis Manager To Quit

  8/25/2004